Active Clinical Trials

Malignant Mesothelioma – Can we Improve Quality of Life

By April 24, 2017 No Comments

Condition

Mesothelioma, Malignant

Estimated Enrollment: 319

Age Group: 18 Years and older   (Adult, Senior)

Gender: All

Study Type: Interventional

Study Design Allocation: Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: No masking|Primary Purpose: Supportive Care

Study ID Numbers: PHT/2013/46

Study First Received: January 4, 2017

Last Updated: March 1, 2017

Estimated Primary Completion Date: March 2017

 

Primary Outcome Measures:

EORTC C-30 Quality of Life|Health Related Quality of Life (HRQoL) in Patients|Patient Mood|Primary Caregiver Health Related Quality of Life (HRQoL)|Primary Caregiver Mood|Overall Survival between the two study groups|Healthcare Utilisation between the two study groups|Primary caregiver satisfaction with end of life care

Sponsors and Collaborators:

Portsmouth Hospitals NHS Trust|British Lung Foundation|University of Oxford

Website Link: https://ClinicalTrials.gov/show/NCT03068117

Leave a Reply

Call Now